{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:03:22Z","timestamp":1756339402468,"version":"3.44.0"},"reference-count":30,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:p>Infection with Helicobacter pylori has been designated a cause of human cancer by the International Agency for Research on Cancer (part of the World Health Organization).1 The infection, which affects 30-50% of adults in Europe and over 80% in parts of the developing world, is the commonest cause of chronic non-atrophic gastritis, which, if severe and prolonged, can lead to loss of gastric glands (atrophic gastritis) and intestinal metaplasia: both markedly increase the risk of developing gastric cancer.1<jats:sup>,<\/jats:sup>2 H. pylori infection appears, by itself, capable of causing gastric mucosal atrophy,3 and there is some evidence that prolonged reduction in acid secretion, whether induced by disease or drugs, might accelerate this change.4<jats:sup>,<\/jats:sup>5 These observations pose difficult dilemmas for doctors treating patients with gastric disorders, especially those needing long-term treatment with potent antisecretory drugs.<\/jats:p>","DOI":"10.1136\/dtb.1998.36857","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"57-59","source":"Crossref","is-referenced-by-count":2,"title":["Helicobacter pylori and gastric cancer"],"prefix":"10.1136","volume":"36","member":"239","published-online":{"date-parts":[[1998,8,1]]},"reference":[{"key":"2025082701265921000_36.8.57.1","unstructured":"International Agency for Research on Cancer Monographs on the evaluation of carcinogenic risks to humans Volume 61 Schistosomes, liver flukes and Helicobacter pylori , Working Group, Lyon, 7-14 June 1994 Lyon: IARC 1995 177\u00e2\u0080\u0093240."},{"key":"2025082701265921000_36.8.57.2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ijc.2910350206","article-title":"Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data","volume":"35","author":"Sipponen","year":"1985","journal-title":"Int J Cancer"},{"key":"2025082701265921000_36.8.57.3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(95)91084-0","article-title":"Long-term sequelae of Helicobacter pylori gastritis","volume":"345","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"key":"2025082701265921000_36.8.57.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91084-0"},{"key":"2025082701265921000_36.8.57.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"2025082701265921000_36.8.57.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.11.s1.5.x"},{"key":"2025082701265921000_36.8.57.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507063330107"},{"key":"2025082701265921000_36.8.57.8","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90938-D"},{"key":"2025082701265921000_36.8.57.9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":"Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii","volume":"325","author":"Nomura","year":"1991","journal-title":"N Engl J Med"},{"key":"2025082701265921000_36.8.57.10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N Engl J Med"},{"key":"2025082701265921000_36.8.57.11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.302.6788.1302","article-title":"Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation","volume":"302","author":"Forman","year":"1991","journal-title":"BMJ"},{"key":"2025082701265921000_36.8.57.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6788.1302"},{"key":"2025082701265921000_36.8.57.13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(98)70422-6","article-title":"Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer","volume":"114","author":"Huang","year":"1998","journal-title":"Gastroenterology"},{"key":"2025082701265921000_36.8.57.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70422-6"},{"key":"2025082701265921000_36.8.57.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70076-3"},{"key":"2025082701265921000_36.8.57.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.3.297"},{"key":"2025082701265921000_36.8.57.17","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.3.345"},{"key":"2025082701265921000_36.8.57.18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.3.346"},{"key":"2025082701265921000_36.8.57.19","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.2.179"},{"key":"2025082701265921000_36.8.57.20","first-page":"639","article-title":"Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer","volume":"6","author":"Uemura","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025082701265921000_36.8.57.21","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S0016-5085(97)80022-4","article-title":"For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection?","volume":"113","author":"","year":"1997","journal-title":"Gastroenterology"},{"key":"2025082701265921000_36.8.57.22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0016-5085(97)70075-1","article-title":"Helicobacter pylori infection and chronic gastric acid hyposecretion","volume":"113","author":"El-Omar","year":"1997","journal-title":"Gastroenterology"},{"key":"2025082701265921000_36.8.57.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70075-1"},{"key":"2025082701265921000_36.8.57.24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.1997.00196.x","article-title":"H-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients","volume":"11","author":"Meining","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"2025082701265921000_36.8.57.25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00196.x"},{"key":"2025082701265921000_36.8.57.26","unstructured":"Lundell L Havu N Andersson A . Gastritis development and acid suppression therapy revisited. Results of a randomised clinical study with long-term follow-up. 97th Annual Meeting of the American Gastroenterological Association Gastroenterol 1997; 112 [abstractA28]."},{"key":"2025082701265921000_36.8.57.27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.41.1.8","article-title":"(EHPSG). Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report","volume":"41","year":"1997","journal-title":"Gut"},{"key":"2025082701265921000_36.8.57.28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"2025082701265921000_36.8.57.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70024-6"},{"key":"2025082701265921000_36.8.57.30","first-page":"588","article-title":"An inverse relation between cagA + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma","volume":"58","author":"Chow","year":"1998","journal-title":"Cancer Res"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.1998.36857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:27:11Z","timestamp":1756283231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.1998.36857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[1998,8,1]]},"published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1136\/dtb.1998.36857"],"URL":"https:\/\/doi.org\/10.1136\/dtb.1998.36857","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}